Cargando…

Are NKT cells a useful predictor of COVID-19 severity?

Detalles Bibliográficos
Autores principales:	Koay, Hui-Fern, Gherardin, Nicholas A., Nguyen, Thi H.O., Zhang, Wuji, Habel, Jennifer R., Seneviratna, Rebecca, James, Fiona, Holmes, Natasha E., Smibert, Olivia C., Gordon, Claire L., Trubiano, Jason A., Kedzierska, Katherine, Godfrey, Dale I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768020/ https://www.ncbi.nlm.nih.gov/pubmed/35104438 http://dx.doi.org/10.1016/j.immuni.2022.01.005

Ejemplares similares

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2021)

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
por: Copaescu, Ana, et al.
Publicado: (2021)

Diverse MR1-restricted T cells in mice and humans
por: Koay, Hui-Fern, et al.
Publicado: (2019)

Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021)

Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral Replication
por: Gordon, Claire L, et al.
Publicado: (2021)

New ways to turn on NKT cells
por: Godfrey, Dale Ian, et al.
Publicado: (2011)

1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
por: Smibert, Olivia, et al.
Publicado: (2018)

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
por: Copaescu, Ana, et al.
Publicado: (2020)

The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study
por: Trubiano, Jason A, et al.
Publicado: (2018)

Differential antigenic requirements by diverse MR1‐restricted T cells
por: Seneviratna, Rebecca, et al.
Publicado: (2022)

Regulatory iNKT cells lack PLZF expression and control T(reg) cell and macrophage homeostasis in adipose tissue
por: Lynch, Lydia, et al.
Publicado: (2014)

1787. The Safety and Efficacy of an Oral Penicillin Rechallenge Program in Cancer Patients: A Pilot Multicenter Study
por: Smibert, Olivia, et al.
Publicado: (2018)

Immunosuppression for COVID-19: repurposing medicines in a pandemic
por: Shivakumar, Senthuran, et al.
Publicado: (2020)

An unconventional view of COVID-19 T cell immunity
por: Koay, Hui-Fern, et al.
Publicado: (2020)

Development of mucosal‐associated invariant T cells
por: Koay, Hui‐Fern, et al.
Publicado: (2018)

Activation of Invariant NKT Cells Exacerbates Experimental Visceral Leishmaniasis
por: Stanley, Amanda C., et al.
Publicado: (2008)

2743. Pre-Transplant Human T-Lymphotropic Virus Screening In Allogeneic Hematopoietic Stem Cell Transplant Recipients At A Large Metropolitan Tertiary Referral Centre In Melbourne, Australia
por: Paykin, Gabriel, et al.
Publicado: (2023)

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2022)

Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations
por: Habel, Jennifer R., et al.
Publicado: (2023)

Influenza, but not SARS‐CoV‐2, infection induces a rapid interferon response that wanes with age and diminished tissue‐resident memory CD8(+) T cells
por: Nguyen, Thi HO, et al.
Publicado: (2021)

Differential Requirement for the CD45 Splicing Regulator hnRNPLL for Accumulation of NKT and Conventional T Cells
por: Yabas, Mehmet, et al.
Publicado: (2011)

Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021)

Differential antitumor immunity mediated by NKT cell subsets in vivo
por: Crowe, Nadine Y., et al.
Publicado: (2005)

COVID-MATCH65—A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2
por: Trubiano, Jason A., et al.
Publicado: (2020)

IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma
por: Coquet, Jonathan M, et al.
Publicado: (2013)

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
por: Nguyen, Thi H.O., et al.
Publicado: (2021)

Divergent SATB1 expression across human life span and tissue compartments
por: Nüssing, Simone, et al.
Publicado: (2019)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

Longitudinal analysis of invariant natural killer T cell activation reveals a cMAF-associated transcriptional state of NKT10 cells
por: Kane, Harry, et al.
Publicado: (2022)

Response to Are NKT cells a useful predictor of COVID-19 severity?
por: Kreutmair, Stefanie, et al.
Publicado: (2022)

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
por: Koutsakos, Marios, et al.
Publicado: (2021)

Differential location of NKT and MAIT cells within lymphoid tissue
por: Johnson, Darryl N., et al.
Publicado: (2022)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis
por: Awad, Andrew, et al.
Publicado: (2021)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1- and NKT2-Type iNKT Cells
por: Yasuoka, Toshiaki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e694m5i31bjmd5qcsadmfp0d9r